Regulation & law · 06/11/2001

U.S. Patent for Antileishmanial Composition Available for Licensing

The U.S. Patent Office has made available U.S. Patent No. 6,284,739, which covers an antileishmanial composition for topical application, for licensing to non-exclusive, exclusive, or partially exclusive terms, with the U.S. Government retaining rights as represented by the Secretary of the Army.